Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
Level 5 - mechanism / opinion, no new human data
Preclinical rodent study (animal research)
PubMed 24327450 · doi:10.1177/0269881113513850
What was done
Dual-probe microdialysis and concurrent locomotor activity tracking were conducted in the prefrontal cortex (PFC) and striatum of conscious, freely-moving rats. Researchers compared oral doses across therapeutically relevant and psychostimulant ranges for lisdexamfetamine (0.5, 1.5, 4.5 mg/kg d-amphetamine base equivalent), methylphenidate (3, 10, 30 mg/kg base), and modafinil (100, 300, 600 mg/kg base) on dopamine, noradrenaline, and serotonin (5-HT) efflux.
What was found
Lisdexamfetamine, methylphenidate, and modafinil all increased dopamine and noradrenaline efflux in the PFC and dopamine in the striatum. Only lisdexamfetamine increased 5-HT efflux in both regions. Lisdexamfetamine produced larger and more sustained catecholaminergic effects than methylphenidate or modafinil. Striatal dopamine efflux correlated linearly with locomotor activity for lisdexamfetamine and methylphenidate, but not modafinil. Regression slopes showed lisdexamfetamine permitted greater extracellular dopamine increases without causing locomotor activation compared to methylphenidate. Specific numeric values, variance, and sample sizes were not provided in the abstract.
Why it matters
The findings demonstrate in a rodent model that lisdexamfetamine provides a more sustained neurochemical profile and greater separation between central dopamine elevation and overt locomotor stimulation than methylphenidate.
Limits
This is an animal study in healthy rats, limiting direct translation to human ADHD neurobiology or pharmacokinetics. The abstract omits sample sizes, exact concentrations, numeric effect sizes, and statistical variance metrics.
Cited by
- supports ADHD medications such as Ritalin and Adderall increase brain levels of both dopamine and norepinephrine.